Currently, the company has assembled a cross-disciplinary entrepreneurial team with a common ideal and has initially established two core technology platforms with independent intellectual property rights: the "end-to-end industrial enzyme integrated development technology platform" and the "end-to-end industrial strain integrated development technology platform".
WELI will continue to invest in research and development, work hard, adhere to the bio+ strategy, accelerate technological innovation, and strive to become a leader in China's functional chemical biological solutions, contributing to the leapfrog development of China's bio-manufacturing industry.
On May 15, Shandong Micro Zhicheng held the launching ceremony of the synthetic biology pilot research and development platform in Heze Modern Medicine Port. Wang Jing, Deputy Director of the Municipal Modern Medical Port Management Service Center, Zhang Hongling,
On January 29, the Ministry of Industry and Information Technology, the Ministry of Education, the Ministry of Science and Technology, the Ministry of Transport, the Ministry of Culture and Tourism, the State-owned Assets Supervision and Administration Commission of the State Council,
On June 18-19, 2024, the first CPHI Biomanufacturing Innovation and Development Conference 2024 was held in Shanghai, with the theme of "Synthetic Biology Empowering Industry Upgrading".
On October 24, 2023, the General Office of the Shanghai Municipal People's Government issued a notice on the issuance of the "Shanghai Action Plan for Accelerating Synthetic Biology Innovation and Building a High-end Biomanufacturing Industry Cluster (2023-2025)".